Glyoxal inactivates glutamate transporter-1 in cultured rat astrocytes

Neuropathology

Volumn 25, Issue 1, 2005, Pages 27-36

  Kawaguchi, Motoko ^a   Shibata, Noriyuki ^a   Horiuchi, Seikoh ^b   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

ALS; Astrocyte; Glutamate transporter 1; Glyoxal; N (carboxymethyl)lysine

Indexed keywords

6 N CARBOXYMETHYLLYSINE; GLUTAMATE TRANSPORTER; GLUTAMINE; GLYOXAL; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MOTONEURON; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SPINAL CORD;

AMINO ACID TRANSPORT SYSTEM X-AG; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTAMIC ACID; GLYOXAL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYSINE; RATS;

EID: 16444371250     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2004.00579.x     Document Type: Article

References (47)

1. Ince PG. Neuropathology. In: Brown RH Jr, Meininger V, Swash M (eds) Amyotrophic Lateral Sclerosis. London: Martin Dunitz, 2000; 83-112.
2. Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M. Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 143-161.
3. Jackson M, Rothstein JD. Excitotoxicity in amyotrophic lateral sclerosis. In: Brown RH Jr, Meininger V, Swash M (eds) Amyotrophic Lateral Sclerosis. London: Martin Dunitz, 2000; 263-277.
4. Ince P, Stout N, Shaw P et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993; 19: 291-299.
5. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 6591-6595.
6. Rothstein JD, Dykes-Hoberg M, Pardo CA et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675-686.
7. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84.
8. Bruijn LI, Becher MW, Lee MK et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338.
9. Howland DS, Liu J, She Y et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 2002; 99: 1604-1609.
10. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000; 32: 1-14.
11. Miyata T, Wada Y, Cai Z et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170-1181.
12. Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996; 737: 195-200.
13. Horie K, Miyata T, Maeda K et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100: 2995-3004.
14. Horie K, Miyata T, Yasuda T et al. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commun 1997; 236: 327-332.
15. Hipkiss AR. Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 1998; 30: 863-868.
16. Jadoul M, Ueda Y, Yasuda Y et al. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress". Kidney Int 1999; 55: 2487-2492.
17. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 293-298.
18. Shibata N, Nagai R, Miyata S et al. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol (Berl) 2000; 100: 275-284.
19. Reddy VP, Obrenovich ME, Atwood CS, Perry G, Smith MA. Involvement of Maillard reactions in Alzheimer disease. Neurotoxicol Res 2002; 4: 191-209.
20. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 2001; 21: 82-92.
21. Shibata N, Hirano A, Hedley-Whyte ET et al. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol (Berl) 2002; 104: 171-178.
22. Comporti M. Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res 1998; 28: 623-635.
23. Pedersen WA, Fu W, Keller JN et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998; 44: 819-824.
24. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998; 22: 149-160.
25. Pedersen WA, Cashman NR, Mattson MP. The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp Neurol 1999; 155: 1-10.
26. Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995; 270: 10017-10026.
27. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, N epsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996; 271: 9982-9986.
28. Nagai R, Ikeda K, Higashi T et al. Hydroxyl radical mediates N epsilon-(carboxymethyl) lysine formation from Amadori product. Biochem Biophys Res Commun 1997; 234: 167-172.
29. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266: 7329-7332.
30. Hayashi T, Odashima A, Tsuchiya H, Naruse H. Automated amino acid analyzar based on reversed-phase ion pair chromatography (in Japanese with English abstract). Bunseki Kagaku 1983; 32: 692-697.
31. Hayashi T, Komaki M, Tsuchiya H, Matuda F, Naruse H. Development of gradient programmer and its application to automated amino acid analyzer based on reversed phase ion pair chromatography (in Japanese with English abstract). Bunseki Kagaku 1986; 35: 949-954.
32. Malaga N, Imamura K, Watanabe Y. Effect of 6R-tetrahydrobiopterin on neurotransmitter release and dopamine signal transmission in rat striatum (in Japanese with English abstract). Brain Sci Mental Disorders 1991; 2: 169-114.
33. +-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol 1998; 53: 355-369.
34. Blin O, Samuel D, Nieoullon A, Serratice G. Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiat 1994; 57: 119-120.
35. Kanai Y. Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications. Curr Opin Cell Biol 1997; 9: 565-572.
36. Ingram EM, Wiseman JW, Tessler S, Emson PC. Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J Neurochem 2001; 79: 564-575.
37. Longuemare MC, Swanson RA. Net glutamate release from astrocytes is not induced by extracellular potassium concentrations attainable in brain. J Neurochem 1997; 69: 879-882.
38. Swanson RA. Astrocyte glutamate uptake during chemical hypoxia in vitro. Neurosci Lett 1992; 147: 143-146.
39. Swanson RA, Farrell K, Simon RP. Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J Cereb Blood Flow Metab 1995; 15: 417-424.
40. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996; 40: 759-766.
41. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 1994; 14: 2924-2932.
42. Volterra A, Trotti D, Racagni G. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol Pharmacol 1994; 46: 986-992.
43. Trotti D, Rossi D, Gjesdal O et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996; 271: 5976-5979.
44. Madl JE, Allen DL. Hyperthermia depletes adenosine triphosphate and decreases glutamate uptake in rat hippocampal slices. Neuroscience 1995; 69: 395-405.
45. Niwa H, Takeda A, Wakai M et al. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 1998; 248: 93-97.
46. Trotti D, Rizzini BL, Rossi D et al. Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci 1997; 9: 1236-1243.
47. Shibata N, Nagai R, Uchida K et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917: 97-104.